7Baggers
 published on: 2025-11-11 01:31:47  newser.com Tue, 11 Nov 2025 07:31:47 GMT
 Fulcrum Therapeutics resumed with a Buy at Stifel  TipRanks Thu, 06 Nov 2025 13:39:52 GMT
 Fulcrum Therapeutics (FULC) Receives Buy Rating and $20 Price Ta  GuruFocus Thu, 06 Nov 2025 13:10:33 GMT
 published on: 2025-11-06 04:16:47  newser.com Thu, 06 Nov 2025 10:16:47 GMT
 published on: 2025-11-05 02:06:58  newser.com Wed, 05 Nov 2025 08:06:58 GMT
 what is leerink partnrs' estimate for fulc fy2025 earnings?  MarketBeat Mon, 03 Nov 2025 07:29:52 GMT
 fy2025 eps forecast for fulcrum therapeutics cut by analyst  MarketBeat Mon, 03 Nov 2025 06:52:48 GMT
 fy2025 eps estimate for fulcrum therapeutics cut by analyst  MarketBeat Mon, 03 Nov 2025 06:51:25 GMT
 published on: 2025-11-02 22:53:39  newser.com Mon, 03 Nov 2025 03:53:39 GMT
 what is hc wainwright's estimate for fulc q1 earnings?  MarketBeat Sat, 01 Nov 2025 12:55:27 GMT
 fulcrum therapeutics (nasdaq:fulc) price target raised to $7.00  MarketBeat Fri, 31 Oct 2025 15:23:32 GMT
 published on: 2025-10-31 05:47:11  newser.com Fri, 31 Oct 2025 10:47:11 GMT
 how to forecast fulcrum therapeutics inc. trends using time series  newser.com Fri, 31 Oct 2025 04:37:08 GMT
 Fulcrum Therapeutics Narrows Loss And Gains Wall Street Praise  Finimize Thu, 30 Oct 2025 16:21:40 GMT

Fulcrum Therapeutics, Inc
(NASDAQ:FULC) 

FULC stock logo

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that is i...

Founded: 2015
Full Time Employees: 73
CEO: Robert J. Gould  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends